CAS Number23031-25-6
Synonyms1-(3,5-dihydroxyphenyl)-2-(tert-butylamino)-ethanol; TelMisartan API; SNGP-003-04H08; MICARDIS; [3H]-Telmisartan; BIBR 277; BIBR 277SE; 4'-[(2-n-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)-methyl]-2-carboxy-biphenyl; 5-(1-Hydroxy-2-tert-butylamino-ethyl)benzene-1,3-diol; TIMISHATAN; Telmisaran; 5-[2-(tertbutylamino)-1-hydroxyethyl]benzene-1,3-diol; PRITOR; [3H]-Terbutaline; EINECS 245-385-8; TU-199; TIMETAZIDINE
Molecular FormulaC12H19NO3
Molecular Weight223.27
Purity98.00%
Density1.171 g/cm3
Boiling Point419.2ºC at 760 mmHg
Melting Point204-208ºC
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 23031-25-6 |
| Catalog No. | 2A-9039144 |
| Chinese Name | 特布他林 |
| Synonyms | 1-(3,5-dihydroxyphenyl)-2-(tert-butylamino)-ethanol; TelMisartan API; SNGP-003-04H08; MICARDIS; [3H]-Telmisartan; BIBR 277; BIBR 277SE; 4'-[(2-n-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)-methyl]-2-carboxy-biphenyl; 5-(1-Hydroxy-2-tert-butylamino-ethyl)benzene-1,3-diol; TIMISHATAN; Telmisaran; 5-[2-(tertbutylamino)-1-hydroxyethyl]benzene-1,3-diol; PRITOR; [3H]-Terbutaline; EINECS 245-385-8; TU-199; TIMETAZIDINE |
| Molecular Formula | C12H19NO3 |
| Molecular Weight | 223.27 |
| Purity | 98.00 |
| Density | 1.171 g/cm3 |
| Boiling Point | 419.2ºC at 760 mmHg |
| Melting Point | 204-208ºC |
| Application | Terbutaline is a short-acting agonist of β2-adrenergic receptors (β2-AR). Terbutaline is the active metabolite of bambuterol and is used as a bronchodilator and to prevent premature birth [1][2]. |
| HTC | 2942000000 |
| SMILES | CC(C)(C)NCC(O)c1cc(O)cc(O)c1 |
| InChI | InChI=1S/C12H19NO3/c1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8/h4-6,11,13-16H,7H2,1-3H3 |
| InChI Key | XWTYSIMOBUGWOL-UHFFFAOYSA-N |
| NACRES Code | NA.24 |
| UNSPSC | 41116107 |
| MSDS | msds/39144_1_23031_25_6.pdf |
| Use of | Terbutaline is a short-acting agonist of β2-adrenergic receptor (β2-AR) . Terbutaline is an active metabolite of bambuterol and used as a bronchodilator and to prevent premature labor[1][2]. Properties Name terbutaline Synonym More Synonyms KWD 2019 Biological Activity Description Terbutaline is a short-acting agonist of β2-adrenergic receptor (β2-AR) . Terbutaline is an active metabolite of bambuterol and used as a bronchodilator and to prevent premature labor[1][2]. Related Catalog Research Areas >> Endocrinology Signaling Pathways >> GPCR/G Protein >> Adrenergic Receptor Beta-2 adrenergic receptor References [1]. Hoffmann C, et al. Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol. 2004 Feb;369(2):151-9. [2]. Gaudet LM, et al. Effectiveness of terbutaline pump for the prevention of preterm birth. A systematic review and meta-analysis. PLoS One. 2012;7(2):e31679. Chemical & Physical Properties Molecular Formula C12H19NO3 Exact Mass 225.13600 PSA 72.72000 LogP 1.91020 Index of Refraction 1.4596 (estimate) InChIKey XWTYSIMOBUGWOL-UHFFFAOYSA-N Toxicological Information CHEMICAL IDENTIFICATION RTECS NUMBER : CHEMICAL NAME : Benzyl alcohol, alpha-((t-butylamino)methyl)-3,5-dihydroxy- CAS REGISTRY NUMBER : 23031-25-6 LAST UPDATED : DATA ITEMS CITED : MOLECULAR FORMULA : C12-H19-N-O3 MOLECULAR WEIGHT : WISWESSER LINE NOTATION : QR CQ EYQ1MX1&1&1 HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Multiple routes SPECIES OBSERVED : Human - woman DOSE/DURATION : TOXIC EFFECTS : Cardiac - other changes REFERENCE : JAMAAP JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- Volume(issue)/page/year: 244,692,1980 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : SPECIES OBSERVED : Human - man DOSE/DURATION : TOXIC EFFECTS : Behavioral - tremor Cardiac - arrhythmias (including changes in conduction) Cardiac - change in rate REFERENCE : NEJMAG New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- Volume(issue)/page/year: 300,143,1979 ** REPRODUCTIVE DATA ** TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Multiple routes 5660 ug/kg SEX/DURATION : female 32-34 week(s) after conception TOXIC EFFECTS : Reproductive - Effects on Newborn - Apgar score (human only) Reproductive - Effects on Newborn - biochemical and metabolic REFERENCE : JOPDAB Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- Volume(issue)/page/year: 94,449,1979 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SEX/DURATION : female 17-19 day(s) after conception TOXIC EFFECTS : Reproductive - Specific Developmental Abnormalities - respiratory system Reproductive - Specific Developmental Abnormalities - other developmental abnormalities REFERENCE : PEREBL Pediatric Research. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1967- Volume(issue)/page/year: 25,617,1989 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SEX/DURATION : female 17-19 day(s) after conception TOXIC EFFECTS : Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - Central Nervous System REFERENCE : BRBUDU Brain Research Bulletin. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1976- Volume(issue)/page/year: 23,263,1989 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SEX/DURATION : female 17-19 day(s) after conception TOXIC EFFECTS : Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - endocrine system REFERENCE : RCOCB8 Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- Volume(issue)/page/year: 76,269,1992 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous 62500 ng/kg SEX/DURATION : female 16-20 day(s) after conception TOXIC EFFECTS : Reproductive - Maternal Effects - other effects REFERENCE : BMMBES Biochemical Medicine and Metabolic Biology. (Academic Press, Inc., Journal Customer Service, POB 6250, Duluth, MN 55802-0250) V.35- 1986- Volume(issue)/page/year: 52,128,1994 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X4191 No. of Facilities: 58 (estimated) No. of Industries: 1 No. of Occupations: 2 No. of Employees: 1405 (estimated) No. of Female Employees: 941 (estimated) Safety Information RIDADR UN 3077 9 HS Code 2942000000 |
| Tax Rebate | 13.0% |
| Supervision | A. Customs clearance form for inbound goods B. Customs clearance form for outbound goods |
| Inspection | R. Hygiene supervision and inspection of imported food S. Hygiene supervision and inspection of exported food |
| Transport Info | Product name: Supervision conditions A. Customs clearance form for inbound goods B. Customs clearance form for outbound goods |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Dimethyl 4-methoxyisophthalate | 22955-73-3 | 2A-9039123 |
| trans-Mentha-2,8-dien-1-ol | 22972-51-6 | 2A-9039127 |
| N-(3-Aminophenyl)propionamide | 22987-10-6 | 2A-9039130 |
| 4-Bromo-2-nitrobenzyl alcohol | 22996-19-6 | 2A-9039133 |
| 1-(4-Methyloxazol-5-yl)ethanone | 23012-19-3 | 2A-9039141 |
| Terbutaline hemisulfate | 23031-32-5 | 2A-9039145 |
| 1,2-Benzisothiazol-3-amine | 23031-78-9 | 2A-9039147 |
| 1-Bromo-4-(phenylsulfonyl)benzene | 23038-36-0 | 2A-9039148 |
| 5-Thiocyanatothiazol-2-ylamine | 23056-10-2 | 2A-9039149 |
| N-Phenylpiperidin-4-amine | 23056-29-3 | 2A-9039150 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS